Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Our Science – Choyke Website

Peter L. Choyke, M.D., F.A.C.R.

Selected Publications

1)  Johnson LM, Turkbey B, Figg WD, Choyke PL.
Multiparametric MRI in prostate cancer management.
Nat Rev Clin Oncol. 11: 346-53, 2014.
2)  Turkbey B, Mani H, Aras O, Ho J, Hoang A, Rastinehad AR, Agarwal H, Shah V, Bernardo M, Pang Y, Daar D, McKinney YL, Linehan WM, Kaushal A, Merino MJ, Wood BJ, Pinto PA, Choyke PL.
Prostate Cancer: Can Multiparametric MR Imaging Help Identify Patients Who Are Candidates for Active Surveillance?.
Radiology. 268: 144-52, 2013.
3)  Turkbey B, Mena E, Shih J, Pinto PA, Merino MJ, Lindenberg ML, Bernardo M, McKinney YL, Adler S, Owenius R, Choyke PL, Kurdziel KA.
Localized prostate cancer detection with 18F FACBC PET/CT: comparison with MR imaging and histopathologic analysis.
Radiology. 270: 849-56, 2014.
4)  Sano K, Nakajima T, Choyke PL, Kobayashi H.
The effect of photoimmunotherapy followed by liposomal daunorubicin in a mixed tumor model: a demonstration of the super-enhanced permeability and retention effect after photoimmunotherapy.
Mol. Cancer Ther. 13: 426-32, 2014.
5)  Mitsunaga M, Ogawa M, Kosaka N, Rosenblum LT, Choyke PL, Kobayashi H.
Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules.
Nat Med. 17:: 1685-91, 2011.
6)  Harada T, Sano K, Sato K, Watanabe R, Yu Z, Hanaoka H, Nakajima T, Choyke PL, Ptaszek M, Kobayashi H.
Activatable organic near-infrared fluorescent probes based on a bacteriochlorin platform: synthesis and multicolor in vivo imaging with a single excitation.
Bioconjug. Chem. 25: 362-9, 2014.
7)  Logan JK, Walton-Diaz A, Rais-Bahrami S, Merino MJ, Turkbey B, Choyke PL, Pinto PA.
Changes observed in multiparametric prostate magnetic resonance imaging characteristics correlate with histopathological development of chronic granulomatous prostatitis after intravesical Bacillus Calmette-Guerin therapy.
J Comput Assist Tomogr. 38: 274-6, 2014.
8)  Garvey B, Türkbey B, Truong H, Bernardo M, Periaswamy S, Choyke PL.
Clinical value of prostate segmentation and volume determination on MRI in benign prostatic hyperplasia.
Diagn Interv Radiol. [Epub ahead of print], 2014.
9)  Longmire MR, Ogawa M, Choyke PL, Kobayashi H.
Dendrimers as high relaxivity MR contrast agents.
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 6: 155-62, 2014.
10)  Rais-Bahrami S, Siddiqui MM, Vourganti S, Turkbey B, Rastinehad AR, Stamatakis L, Truong H, Walton-Diaz A, Hoang AN, Nix JW, Merino MJ, Wood BJ, Simon RM, Choyke PL, Pinto PA.
Diagnostic Value of Biparametric MRI as an Adjunct to PSA-based Detection of Prostate Cancer in Men without Prior Biopsies.
BJU Int. [Epub ahead of print], 2014.
11)  Ali T, Nakajima T, Sano K, Sato K, Choyke PL, Kobayashi H.
Dynamic fluorescent imaging with indocyanine green for monitoring the therapeutic effects of photoimmunotherapy.
Contrast Media Mol Imaging. 9: 276-82, 2014.
12)  Nakajima T, Sano K, Sato K, Watanabe R, Harada T, Hanaoka H, Choyke PL, Kobayashi H.
Fluorescence-lifetime molecular imaging can detect invisible peritoneal ovarian tumors in bloody ascites.
Cancer Sci. 105: 308-14, 2014.
13)  Hong CW, Walton-Diaz A, Rais-Bahrami S, Hoang AN, Türkbey B, Stamatakis L, Xu S, Amalou H, Siddiqui MM, Nix JW, Vourganti S, Merino MJ, Choyke PL, Wood BJ, Pinto PA.
Imaging and pathology findings after an initial negative MRI-US fusion-guided and 12-core extended sextant prostate biopsy session.
Diagn Interv Radiol. [Epub ahead of print], 2014.
14)  Turkbey B, Kobayashi H, Hoyt RF, Choyke PL, Nakajima T, Griffiths GL, Bernardo M, Rialon K, Fishman SJ, Sena LM.
Magnetic resonance lymphography of the thoracic duct after interstitial injection of gadofosveset trisodium: a pilot dosing study in a porcine model.
Lymphat Res Biol. 12: 32-6, 2014.
15)  Watanabe R, Sato K, Hanaoka H, Harada T, Nakajima T, Kim I, Paik CH, Wu AM, Choyke PL, Kobayashi H.
Minibody-indocyanine green based activatable optical imaging probes: the role of short polyethylene glycol linkers.
ACS Med Chem Lett. 5: 411-5, 2014.
16)  Wulfert S, Kratochwil C, Choyke PL, Afshar-Oromieh A, Mier W, Kauczor H, Schenk J, Haberkorn U, Giesel FL.
Multimodal Imaging for Early Functional Response Assessment of (90)Y-/ (177)Lu-DOTATOC Peptide Receptor Targeted Radiotherapy with DW-MRI and (68)Ga-DOTATOC-PET/CT.
Mol Imaging Biol. [Epub ahead of print], 2014.
17)  Johnson LM, Rothwax JT, Turkbey B, Rais-Bahrami S, Wood BJ, Figg WD, Choyke PL, Merino MJ, Pinto PA.
Multiparametric Magnetic Resonance Imaging of the Prostate Aids to Detect Lesion Progression.
J Comput Assist Tomogr. [Epub ahead of print], 2014.
18)  Volkin D, Turkbey B, Hoang AN, Rais-Bahrami S, Yerram N, Walton-Diaz A, Nix JW, Wood BJ, Choyke PL, Pinto PA.
Multiparametric MRI and Subsequent MR/Ultrasound Fusion-Guided Biopsy Increase the Detection of Anteriorly Located Prostate Cancers.
BJU Int. [Epub ahead of print], 2014.
19)  Rais-Bahrami S, Türkbey B, Rastinehad AR, Walton-Diaz A, Hoang AN, Siddiqui MM, Stamatakis L, Truong H, Nix JW, Vourganti S, Grant KB, Merino MJ, Wood BJ, Choyke PL, Pinto PA.
Natural history of small index lesions suspicious for prostate cancer on multiparametric MRI: recommendations for interval imaging follow-up.
Diagn Interv Radiol. [Epub ahead of print], 2014.
20)  Sato K, Watanabe R, Hanaoka H, Harada T, Nakajima T, Kim I, Paik CH, Choyke PL, Kobayashi H.
Photoimmunotherapy: Comparative effectiveness of two monoclonal antibodies targeting the epidermal growth factor receptor.
Mol Oncol. [Epub ahead of print], 2014.
21)  Hong CW, Amalou H, Xu S, Turkbey B, Yan P, Kruecker J, Pinto PA, Choyke PL, Wood BJ.
Prostate Biopsy for the Interventional Radiologist.
J Vasc Interv Radiol. 25: 675-684, 2014.
22)  Rais-Bahrami S, Turkbey B, Grant KB, Pinto PA, Choyke PL.
Role of multiparametric magnetic resonance imaging in the diagnosis of prostate cancer.
Curr Urol Rep. 15: 387, 2014.
23)  Choyke PL.
Science to Practice: Percutaneous Biopsies in the NIR Future-Will Fluorescence Guide the Way?.
Radiology. 271: 623-4, 2014.
24)  Seidel J, Bernardo ML, Wong KJ, Xu B, Williams MR, Kuo F, Jagoda EM, Basuli F, Li C, Griffiths GL, Green MV, Choyke PL.
Simultaneous ECG-gated PET imaging of multiple mice.
Nucl. Med. Biol. [Epub ahead of print], 2014.
25)  Nakajima T, Sato K, Hanaoka H, Watanabe R, Harada T, Choyke PL, Kobayashi H.
The effects of conjugate and light dose on photo-immunotherapy induced cytotoxicity.
BMC Cancer. 14: 389, 2014.
26)  Smedley J, Turkbey B, Bernardo ML, Del Prete GQ, Estes JD, Griffiths GL, Kobayashi H, Choyke PL, Lifson JD, Keele BF.
Tracking the Luminal Exposure and Lymphatic Drainage Pathways of Intravaginal and Intrarectal Inocula Used in Nonhuman Primate Models of HIV Transmission.
PLoS ONE. 9: e92830, 2014.
27)  Thomas A, Mena E, Kurdziel K, Venzon D, Khozin S, Berman AW, Choyke P, Szabo E, Rajan A, Giaccone G.
18F-Fluorodeoxyglucose Positron Emission Tomography in the Management of Patients with Thymic Epithelial Tumors.
Clin. Cancer Res. 19: 1487-93, 2013.
28)  Stamatakis L, Siddiqui MM, Nix JW, Logan J, Rais-Bahrami S, Walton-Diaz A, Hoang AN, Vourganti S, Truong H, Shuch B, Parnes HL, Turkbey B, Choyke PL, Wood BJ, Simon RM, Pinto PA.
Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer.
Cancer. 119: 3359-66, 2013.
29)  Sano K, Nakajima T, Ali T, Bartlett DW, Wu AM, Kim I, Paik CH, Choyke PL, Kobayashi H.
Activatable fluorescent cys-diabody conjugated with indocyanine green derivative: consideration of fluorescent catabolite kinetics on molecular imaging.
J Biomed Opt. 18: 101304, 2013.
30)  Sano K, Mitsunaga M, Nakajima T, Choyke PL, Kobayashi H.
Acute Cytotoxic Effects of Photoimmunotherapy Assessed by 18F-FDG PET.
J. Nucl. Med. 54: 770-5, 2013.
31)  Bhutani M, Turkbey B, Tan E, Kemp TJ, Pinto LA, Berg AR, Korde N, Minter AR, Weiss BM, Mena E, Lindenberg L, Aras O, Purdue MP, Hofmann JN, Steinberg SM, Calvo KR, Choyke PL, Maric I, Kurdziel K, Landgren O.
Bone marrow angiogenesis in myeloma and its precursor disease: a prospective clinical trial.
Leukemia. 28: 413-6, 2013.
32)  Gunay-Aygun M, Font-Montgomery E, Lukose L, Tuchman Gerstein M, Piwnica-Worms K, Choyke P, Daryanani KT, Turkbey B, Fischer R, Bernardini I, Sincan M, Zhao X, Sandler NG, Roque A, Douek DC, Graf J, Huizing M, Bryant JC, Mohan P, Gahl WA, Heller T.
Characteristics of congenital hepatic fibrosis in a large cohort of patients with autosomal recessive polycystic kidney disease.
Gastroenterology. 144: 112-121.e2, 2013.
33)  Turkbey B, Merino MJ, Gallardo EC, Shah V, Aras O, Bernardo M, Mena E, Daar D, Rastinehad AR, Linehan WM, Wood BJ, Pinto PA, Choyke PL.
Comparison of endorectal coil and nonendorectal coil T2W and diffusion-weighted MRI at 3 Tesla for localizing prostate cancer: Correlation with whole-mount histopathology.
J Magn Reson Imaging. [Epub ahead of print], 2013.
34)  Logan JK, Rais-Bahrami S, Turkbey B, Gomella A, Amalou H, Choyke PL, Wood BJ, Pinto PA.
Current Status of MRI and Ultrasound Fusion Software Platforms for Guidance of Prostate Biopsies.
BJU Int. [Epub ahead of print], 2013.
35)  Wood BJ, Choyke P, Turkbey B, Pinto P.
Editorial comment.
J. Urol. 189: 92, 2013.
36)  Ali T, Choyke PL, Kobayashi H.
Endoscopic molecular imaging of cancer.
Future Oncol. 9: 1501-13, 2013.
37)  Alexander VM, Choyke PL, Kobayashi H.
Fluorescent molecular imaging: technical progress and current preclinical and clinical applications in urogynecologic diseases.
Curr. Mol. Med. 13: 1568-78, 2013.
38)  Turkbey B, Fotin SV, Huang RJ, Yin Y, Daar D, Aras O, Bernardo M, Garvey BE, Weaver J, Haldankar H, Muradyan N, Merino MJ, Pinto PA, Periaswamy S, Choyke PL.
Fully Automated Prostate Segmentation on MRI: Comparison With Manual Segmentation Methods and Specimen Volumes.
AJR Am J Roentgenol. 201: W720-9, 2013.
39)  Grant K, Lindenberg ML, Shebel H, Pang Y, Agarwal HK, Bernardo M, Kurdziel KA, Turkbey B, Choyke PL.
Functional and molecular imaging of localized and recurrent prostate cancer.
Eur. J. Nucl. Med. Mol. Imaging. 40 Suppl 1: S48-59, 2013.
40)  Turkbey B, Mena E, Aras O, Garvey B, Grant K, Choyke PL.
Functional and molecular imaging: applications for diagnosis and staging of localised prostate cancer.
Clin Oncol (R Coll Radiol). 25: 451-60, 2013.
41)  Kobayashi H, Watanabe R, Choyke PL.
Improving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target?.
Theranostics. 4: 81-9, 2013.
42)  Nakajima T, Sano K, Choyke PL, Kobayashi H.
Improving the efficacy of Photoimmunotherapy (PIT) using a cocktail of antibody conjugates in a multiple antigen tumor model.
Theranostics. 3: 357-65, 2013.
43)  Siddiqui MM, Rais-Bahrami S, Truong H, Stamatakis L, Vourganti S, Nix J, Hoang AN, Walton-Diaz A, Shuch B, Weintraub M, Kruecker J, Amalou H, Turkbey B, Merino MJ, Choyke PL, Wood BJ, Pinto PA.
Magnetic Resonance Imaging/Ultrasound-Fusion Biopsy Significantly Upgrades Prostate Cancer Versus Systematic 12-core Transrectal Ultrasound Biopsy.
Eur. Urol. 64: 713-9, 2013.
44)  Sano K, Nakajima T, Choyke PL, Kobayashi H.
Markedly enhanced permeability and retention effects induced by photo-immunotherapy of tumors.
ACS Nano. 7: 717-24, 2013.
45)  Mitsunaga M, Tajiri H, Choyke PL, Kobayashi H.
Monoclonal antibody-fluorescent probe conjugates for in vivo target-specific cancer imaging: toward clinical translation.
Ther Deliv. 4: 523-5, 2013.
46)  Nakajima T, Turkbey B, Sano K, Sato K, Bernardo M, Hoyt RF, Choyke PL, Kobayashi H.
MR lymphangiography with intradermal gadofosveset and human serum albumin in mice and primates.
J Magn Reson Imaging. [Epub ahead of print], 2013.
47)  Truong H, Logan J, Turkbey B, Siddiqui MM, Rais-Bahrami S, Hoang AN, Pusateri C, Shuch B, Walton-Diaz A, Vourganti S, Nix J, Stamatakis L, Harris C, Chua C, Choyke PL, Wood BJ, Pinto PA.
MRI characterization of the dynamic effects of 5a-reductase inhibitors on prostate zonal volumes.
Can J Urol. 20: 7002-7, 2013.
48)  Kines RC, Kobayashi H, Choyke PL, Bernardo ML.
Optical imaging of HPV infection in a murine model.
Methods Mol. Biol. 961: 141-50, 2013.
49)  Nayak TK, Bernardo M, Milenic DE, Choyke PL, Brechbiel MW.
Orthotopic Pleural Mesothelioma in Mice: SPECT/CT and MR Imaging with HER1- and HER2-targeted Radiolabeled Antibodies.
Radiology. 267: 173-82, 2013.
50)  Seidel J, Xi W, Kakareka JW, Pohida TJ, Jagoda EM, Green MV, Choyke PL.
Performance characteristics of a positron projection imager for mouse whole-body imaging.
Nucl. Med. Biol. 40: 321-30, 2013.
51)  Kim A, Dombi E, Tepas K, Fox E, Martin S, Wolters P, Balis FM, Jayaprakash N, Turkbey B, Muradyan N, Choyke PL, Reddy A, Korf B, Widemann BC.
Phase I trial and pharmacokinetic study of sorafenib in children with neurofibromatosis type I and plexiform neurofibromas.
Pediatr Blood Cancer. 60: 396-401, 2013.
52)  Dahut WL, Madan RA, Karakunnel JJ, Adelberg D, Gulley JL, Turkbey IB, Chau CH, Spencer SD, Mulquin M, Wright J, Parnes HL, Steinberg SM, Choyke PL, Figg WD.
Phase II clinical trial of cediranib in patients with metastatic castration-resistant prostate cancer.
BJU Int. 111: 1269-80, 2013.
53)  Yang M, Li X, Turkbey B, Choyke PL, Yan P.
Prostate segmentation in MR images using discriminant boundary features.
IEEE Trans Biomed Eng. 60: 479-88, 2013.
54)  Adler S, Kurdziel K, Lindenberg L, Choyke P, Mena E.
J. Nucl. Med. 54: 326-7, 2013.
55)  Choyke PL.
Science to Practice: imaging cancer-associated fibroblasts--no innocent bystanders.
Radiology. 268: 617-8, 2013.
56)  Sano K, Nakajima T, Miyazaki K, Ohuchi Y, Ikegami T, Choyke PL, Kobayashi H.
Short PEG-linkers improve the performance of targeted, activatable monoclonal antibody-indocyanine green optical imaging probes.
Bioconjug. Chem. 24: 811-6, 2013.
57)  Choyke PL, Turkbey B.
The state of prostate MRI in 2013: into the breach.
Oncology (Williston Park, N.Y.). 27: 274, 276, 2013.
58)  Azad N, Yu M, Davidson B, Choyke P, Chen CC, Wood BJ, Venkatesan A, Henning R, Calvo K, Minasian L, Edelman DC, Meltzer P, Steinberg SM, Annunziata CM, Kohn EC.
Translational predictive biomarker analysis of the phase 1b sorafenib and bevacizumab study expansion cohort.
Mol. Cell Proteomics. 12: 1621-31, 2013.
59)  Boyce AM, Shawker TH, Hill SC, Choyke PL, Hill MC, James R, Yovetich NA, Collins MT, Gafni RI.
Ultrasound is Superior to Computed Tomography for Assessment of Medullary Nephrocalcinosis in Hypoparathyroidism.
J. Clin. Endocrinol. Metab. 98: 989-94, 2013.
60)  Rais-Bahrami S, Siddiqui MM, Turkbey B, Stamatakis L, Logan J, Hoang AN, Walton-Diaz A, Vourganti S, Truong H, Kruecker J, Merino MJ, Wood BJ, Choyke PL, Pinto PA.
Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancer.
J. Urol. 190: 1721-7, 2013.
61)  Mena E, Turkbey B, Mani H, Adler S, Valera VA, Bernardo M, Shah V, Pohida T, McKinney Y, Kwarteng G, Daar D, Lindenberg ML, Eclarinal P, Wade R, Linehan WM, Merino MJ, Pinto PA, Choyke PL, Kurdziel KA.
11C-Acetate PET/CT in Localized Prostate Cancer: A Study with MRI and Histopathologic Correlation.
J. Nucl. Med. 53: 538-45, 2012.
62)  Tahmasebi AM, Sharifi R, Agarwal HK, Turkbey B, Bernardo M, Choyke P, Pinto P, Wood B, Kruecker J.
A statistical model-based technique for accounting for prostate gland deformation in endorectal coil-based MR imaging.
Conf Proc IEEE Eng Med Biol Soc. 2012: 5412-5, 2012.
63)  Turkbey B, Huang R, Vourganti S, Trivedi H, Bernardo M, Yan P, Benjamin C, Pinto PA, Choyke PL.
Age-related changes in prostate zonal volumes as measured by high-resolution magnetic resonance imaging (MRI): a cross-sectional study in over 500 patients.
BJU Int. 110: 1642-7, 2012.
64)  O'Brien K, Font-Montgomery E, Lukose L, Bryant J, Piwnica-Worms K, Edwards H, Riney L, Garcia A, Daryanani K, Choyke P, Mohan P, Heller T, Gahl WA, Gunay-Aygun M.
Congenital hepatic fibrosis and portal hypertension in autosomal dominant polycystic kidney disease.
J. Pediatr. Gastroenterol. Nutr. 54: 83-9, 2012.
65)  Turkbey B, Mani H, Aras O, Rastinehad AR, Shah V, Bernardo M, Pohida T, Daar D, Benjamin C, McKinney YL, Linehan WM, Wood BJ, Merino MJ, Choyke PL, Pinto PA.
Correlation of magnetic resonance imaging tumor volume with histopathology.
J. Urol. 188: 1157-63, 2012.
66)  Shah V, Turkbey B, Mani H, Pang Y, Pohida T, Merino MJ, Pinto PA, Choyke PL, Bernardo M.
Decision support system for localizing prostate cancer based on multiparametric magnetic resonance imaging.
Med Phys. 39: 4093-103, 2012.
67)  Barentsz JO, Richenberg J, Clements R, Choyke P, Verma S, Villeirs G, Rouviere O, Logager V, Fütterer JJ.
ESUR prostate MR guidelines 2012.
Eur Radiol. 22: 746-57, 2012.
68)  Mitsunaga M, Kosaka N, Choyke PL, Young MR, Dextras CR, Saud SM, Colburn NH, Sakabe M, Nagano T, Asanuma D, Urano Y, Kobayashi H.
Fluorescence endoscopic detection of murine colitis-associated colon cancer by topically applied enzymatically rapid-activatable probe.
Gut. 62: 1179-86, 2012.
69)  Lim J, Turkbey B, Bernardo M, Bryant LH, Garzoni M, Pavan GM, Nakajima T, Choyke PL, Simanek EE, Kobayashi H.
Gadolinium MRI contrast agents based on triazine dendrimers: relaxivity and in vivo pharmacokinetics.
Bioconjug. Chem. 23: 2291-9, 2012.
70)  Alexander VM, Sano K, Yu Z, Nakajima T, Choyke PL, Ptaszek M, Kobayashi H.
Galactosyl human serum albumin-NMP1 conjugate: a near infrared (NIR)-activatable fluorescence imaging agent to detect peritoneal ovarian cancer metastases.
Bioconjug. Chem. 23: 1671-9, 2012.
71)  Wang S, Liu P, Turkbey B, Choyke P, Pinto P, Summers RM.
Gaussian process inference for estimating pharmacokinetic parameters of dynamic contrast-enhanced MR images.
Med Image Comput Comput Assist Interv. 15: 582-9, 2012.
72)  Mitsunaga M, Nakajima T, Sano K, Kramer-Marek G, Choyke PL, Kobayashi H.
Immediate in vivo target-specific cancer cell death after near infrared photoimmunotherapy.
BMC Cancer. 12: 345, 2012.
73)  Jagoda EM, Lang L, Bhadrasetty V, Histed S, Williams M, Kramer-Marek G, Mena E, Rosenblum L, Marik J, Tinianow JN, Merchant M, Szajek L, Paik C, Cecchi F, Raffensperger K, Jose-Dizon JM, Bottaro DP, Choyke P.
Immuno-PET of the hepatocyte growth factor receptor Met using the 1-armed antibody onartuzumab.
J. Nucl. Med. 53: 1592-600, 2012.
74)  Sano K, Mitsunaga M, Nakajima T, Choyke PL, Kobayashi H.
In vivo breast cancer characterization imaging using two monoclonal antibodies activatably labeled with near infrared fluorophores.
Breast Cancer Res. 14: R61, 2012.
75)  Kosaka N, Mitsunaga M, Choyke PL, Kobayashi H.
In vivo real-time lymphatic draining using quantum-dot optical imaging in mice.
Contrast Media Mol Imaging. 8: 96-100, 2012.
76)  Pang Y, Turkbey B, Bernardo M, Kruecker J, Kadoury S, Merino MJ, Wood BJ, Pinto PA, Choyke PL.
Intravoxel incoherent motion MR imaging for prostate cancer: An evaluation of perfusion fraction and diffusion coefficient derived from different b-value combinations.
Magn Reson Med. 69:: 553-62, 2012.
77)  Yerram NK, Volkin D, Turkbey B, Nix J, Hoang AN, Vourganti S, Gupta GN, Linehan WM, Choyke PL, Wood BJ, Pinto PA.
Low suspicion lesions on multiparametric magnetic resonance imaging predict for the absence of high-risk prostate cancer.
BJU Int. 110: E783-8, 2012.
78)  Kosaka N, Bernardo M, Mitsunaga M, Choyke PL, Kobayashi H.
MR and optical imaging of early micrometastases in lymph nodes: triple labeling with nano-sized agents yielding distinct signals.
Contrast Media Mol Imaging. 7: 247-53, 2012.
79)  Vourganti S, Rastinehad A, Yerram NK, Nix J, Volkin D, Hoang A, Turkbey B, Gupta GN, Kruecker J, Linehan WM, Choyke PL, Wood BJ, Pinto PA.
Multiparametric magnetic resonance imaging and ultrasound fusion biopsy detect prostate cancer in patients with prior negative transrectal ultrasound biopsies.
J. Urol. 188: 2152-7, 2012.
80)  Turkbey B, Choyke PL.
Multiparametric MRI and prostate cancer diagnosis and risk stratification.
Curr Opin Urol. 22:: 310-5, 2012.
81)  Mitsunaga M, Nakajima T, Sano K, Choyke PL, Kobayashi H.
Near-infrared Theranostic Photoimmunotherapy (PIT): Repeated Exposure of Light Enhances the Effect of Immunoconjugate.
Bioconjug. Chem. 23: 604-9, 2012.
82)  Verma S, Turkbey B, Muradyan N, Rajesh A, Cornud F, Haider MA, Choyke PL, Harisinghani M.
Overview of dynamic contrast-enhanced MRI in prostate cancer diagnosis and management.
AJR Am J Roentgenol. 198: 1277-88, 2012.
83)  Kramer-Marek G, Bernardo M, Kiesewetter DO, Bagci U, Kuban M, Aras O, Omer A, Zielinski R, Seidel J, Choyke P, Capala J.
PET of HER2-positive pulmonary metastases with 18F-ZHER2:342 affibody in a murine model of breast cancer: comparison with 18F-FDG.
J. Nucl. Med. 53: 939-46, 2012.
84)  Bouchelouche K, Turkbey B, Choyke PL.
PET/CT and MRI in Bladder Cancer.
J Cancer Sci Ther. S14, 2012.
85)  Kobayashi H, Longmire MR, Choyke PL.
Polychromatic in vivo imaging of multiple targets using visible and near infrared light.
Adv. Drug Deliv. Rev. [Epub ahead of print], 2012.
86)  Gulley JL, Emberton M, Kurhanewicz J, Choyke P.
Progress in prostate cancer imaging.
Urol. Oncol. 30: 938-9, 2012.
87)  Nakajima T, Sano K, Mitsunaga M, Choyke PL, Kobayashi H.
Real-time monitoring of in vivo acute necrotic cancer cell death induced by near infrared photoimmunotherapy using fluorescence lifetime imaging.
Cancer Res. 72: 4622-8, 2012.
88)  Kramer-Marek G, Longmire MR, Choyke PL, Kobayashi H.
Recent advances in optical cancer imaging of EGF receptors.
Curr. Med. Chem. 19: 4759-66, 2012.
89)  Kobayashi H, Choyke PL.
Recipe for a new imaging biomarker: carefully combine target, reagent, and technology.
Kidney Int. 81: 129-31, 2012.
90)  Histed SN, Lindenberg ML, Mena E, Turkbey B, Choyke PL, Kurdziel KA.
Review of functional/anatomical imaging in oncology.
Nucl Med Commun. 33: 349-61, 2012.
91)  Choyke PL.
Science to practice: imaging of cellular microparticles--magic dust or just dirt?.
Radiology. 263: 1-2, 2012.
92)  Kurdziel KA, Shih JH, Apolo AB, Lindenberg L, Mena E, McKinney YY, Adler SS, Turkbey B, Dahut W, Gulley JL, Madan RA, Landgren O, Choyke PL.
The kinetics and reproducibility of 18F-sodium fluoride for oncology using current PET camera technology.
J. Nucl. Med. 53: 1175-84, 2012.
93)  McCann TE, Kosaka N, Choyke PL, Kobayashi H.
The use of fluorescent proteins for developing cancer-specific target imaging probes.
Methods Mol. Biol. 872: 191-204, 2012.
94)  Trivedi H, Turkbey B, Rastinehad AR, Benjamin CJ, Bernardo M, Pohida T, Shah V, Merino MJ, Wood BJ, Linehan WM, Venkatesan AM, Choyke PL, Pinto PA.
Use of patient-specific MRI-based prostate mold for validation of multiparametric MRI in localization of prostate cancer.
Urology. 79: 233-9, 2012.
95)  Nix JW, Turkbey B, Hoang A, Volkin D, Yerram N, Chua C, Linehan WM, Wood B, Choyke P, Pinto PA.
Very distal apical prostate tumours: identification on multiparametric MRI at 3 Tesla.
BJU Int. 110: E694-700, 2012.
96)  Turcotte S, Turkbey B, Barak S, Libutti SK, Alexander HR, Linehan WM, Hughes MS, Nilubol N, Gesuwan K, Millo C, Quezado M, Choyke PL, Kebebew E, Phan GQ.
von Hippel-Lindau disease-associated solid microcystic serous adenomas masquerading as pancreatic neuroendocrine neoplasms.
Surgery. 152: 1106-17, 2012.
97)  Liu W, Turkbey B, Sénégas J, Remmele S, Xu S, Kruecker J, Bernardo M, Wood BJ, Pinto PA, Choyke PL.
Accelerated T(2) mapping for characterization of prostate cancer.
Magn Reson Med. 65: 1400-6, 2011.
98)  McCann TE, Kosaka N, Koide Y, Mitsunaga M, Choyke PL, Nagano T, Urano Y, Kobayashi H.
Activatable Optical Imaging with a Silica-Rhodamine Based Near Infrared (SiR700) Fluorophore: A comparison with cyanine based dyes.
Bioconjug Chem. 22:: 2531-8, 2011.
99)  Longmire MR, Ogawa M, Choyke PL, Kobayashi H.
Biologically Optimized Nanosized Molecules and Particles: More than Just Size.
Bioconjugate Chem. [Epub ahead of print], 2011.
100)  Chen L, Chan T, Choyke PL, Hillman EM, Chi C, Bhujwalla ZM, Wang G, Wang SS, Szabo Z, Wang Y.
CAM-CM: a signal deconvolution tool for in vivo dynamic contrast-enhanced imaging of complex tissues.
Bioinformatics. 27: 2607-2609, 2011.
101)  Tan E, Weiss BM, Mena E, Korde N, Choyke PL, Landgren O.
Current and future imaging modalities for multiple myeloma and its precursor states.
Leuk Lymphoma. [Epub ahead of print], 2011.
102)  Rastinehad AR, Baccala AA, Chung PH, Proano JM, Kruecker J, Xu S, Locklin JK, Turkbey B, Shih J, Bratslavsky G, Linehan WM, Glossop ND, Yan P, Kadoury S, Choyke PL, Wood BJ, Pinto PA.
D'Amico risk stratification correlates with degree of suspicion of prostate cancer on multiparametric magnetic resonance imaging.
J. Urol. 185: 815-20, 2011.
103)  Kojima C, Turkbey B, Ogawa M, Bernardo M, Regino CA, Bryant LH, Choyke PL, Kono K, Kobayashi H.
Dendrimer-based MRI contrast agents: the effects of PEGylation on relaxivity and pharmacokinetics.
Nanomedicine. [Epub ahead of print], 2011.
104)  Turkbey B, Aras O, Karabulut N, Turgut AT, Akpinar E, Alibek S, Pang Y, Erturk SM, El Khouli RH, Bluemke DA, Choyke PL.
Diffusion-weighted MRI for detecting and monitoring cancer: a review of current applications in body imaging.
Diagn Interv Radiol. [Epub ahead of print], 2011.
105)  Turkbey B, Xu S, Kruecker J, Locklin J, Pang Y, Shah V, Bernardo M, Baccala A, Rastinehad A, Benjamin C, Merino MJ, Wood BJ, Choyke PL, Pinto PA.
Documenting the location of systematic transrectal ultrasound-guided prostate biopsies: correlation with multi-parametric MRI.
Cancer Imaging. 11: 31-6, 2011.
106)  Shin IS, Lee S, Kim HS, Yao Z, Regino C, Sato N, Cheng KT, Hassan R, Campo MF, Albone EF, Choyke PL, Pastan I, Paik CH.
Effect of chelator conjugation level and injection dose on tumor and organ uptake of (111)In-labeled MORAb-009, an anti-mesothelin antibody.
Nucl Med Biol. [Epub ahead of print], 2011.
107)  Kelly RJ, Rajan A, Force J, Lopez-Chavez A, Keen C, Cao L, Yu Y, Choyke P, Turkbey B, Raffeld M, Xi L, Steinberg SM, Wright JJ, Kummar S, Gutierrez M, Giaccone G.
Evaluation of KRAS mutations, angiogenic biomarkers, and DCE-MRI in patients with advanced non-small-cell lung cancer receiving sorafenib.
Clin. Cancer Res. 17: 1190-9, 2011.
108)  Kratochwil C, López-Benítez R, Mier W, Haufe S, Isermann B, Kauczor HU, Choyke PL, Haberkorn U, Giesel FL.
Hepatic arterial infusion enhances DOTATOC radiopeptide therapy in patients with neuroendocrine liver metastases.
Endocr. Relat. Cancer. 18: 595-602, 2011.
109)  Kurdziel KA, Kalen JD, Hirsch JI, Wilson JD, Bear HD, Logan J, McCumisky J, Moorman-Sykes K, Adler S, Choyke PL.
Human Dosimetry and Preliminary Tumor Distribution of 18F-Fluoropaclitaxel in Healthy Volunteers and Newly Diagnosed Breast Cancer Patients Using PET/CT.
J. Nucl. Med. 52: 1339-45, 2011.
110)  Mitsunaga M, Kosaka N, Kines RC, Roberts JN, Lowy DR, Schiller JT, Ishihara Y, Hasegawa A, Choyke PL, Kobayashi H.
In vivo longitudinal imaging of experimental human papillomavirus infection in mice with a multicolor fluorescence mini-endoscopy system.
Cancer Prev Res. 4: 767-73, 2011.
111)  Turkbey B, Shah VP, Pang Y, Bernardo M, Xu S, Kruecker J, Locklin J, Baccala AA, Rastinehad AR, Merino MJ, Shih JH, Wood BJ, Pinto PA, Choyke PL.
Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images?.
Radiology. 258: 488-95, 2011.
112)  Pinto PA, Chung PH, Rastinehad AR, Baccala AA, Kruecker J, Benjamin CJ, Xu S, Yan P, Kadoury S, Chua C, Locklin JK, Turkbey B, Shih JH, Gates SP, Buckner C, Bratslavsky G, Linehan WM, Glossop ND, Choyke PL, Wood BJ.
Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging.
J. Urol. 186: 1281-5, 2011.
113)  Mena E, Choyke P, Tan E, Landgren O, Kurdziel K.
Molecular imaging in myeloma precursor disease.
Semin. Hematol. 48: 22-31, 2011.
114)  McCann TE, Kosaka N, Turkbey B, Mitsunaga M, Choyke PL, Kobayashi H.
Molecular imaging of tumor invasion and metastases: the role of MRI.
NMR Biomed. 24: 561-8, 2011.
115)  Turkbey B, Bernardo M, Merino MJ, Wood BJ, Pinto PA, Choyke PL.
MRI of localized prostate cancer: coming of age in the PSA era.
Diagn Interv Radiol. [Epub ahead of print], 2011.
116)  Kummar S, Raffeld M, Juwara L, Horneffer YR, Strassberger A, Allen D, Steinberg SM, Rapisarda A, Spencer SD, Figg WD, Chen X, Turkbey B, Choyke PL, Murgo AJ, Doroshow JH, Melillo G.
Multihistology, Target-Driven Pilot Trial of Oral Topotecan as an Inhibitor of Hypoxia-Inducible Factor-1{alpha} (HIF-1{alpha}) in Advanced Solid Tumors.
Clin Cancer Res. [Epub ahead of print], 2011.
117)  Turkbey B, Mani H, Shah V, Rastinehad AR, Bernardo M, Pohida T, Pang Y, Daar D, Benjamin C, McKinney YL, Trivedi H, Chua C, Bratslavsky G, Shih JH, Linehan WM, Merino MJ, Choyke PL, Pinto PA.
Multiparametric 3T Prostate Magnetic Resonance Imaging to Detect Cancer: Histopathological Correlation Using Prostatectomy Specimens Processed in Customized Magnetic Resonance Imaging Based Molds.
J. Urol. 186: 1818-24, 2011.
118)  Kosaka N, Mitsunaga M, Longmire MR, Choyke PL, Kobayashi H.
Near infrared fluorescence-guided real-time endoscopic detection of peritoneal ovarian cancer nodules using intravenously injected indocyanine green.
Int J Cancer. [Epub ahead of print], 2011.
119)  Figueiras RG, Padhani AR, Goh VJ, Vilanova JC, González SB, Martín CV, Caamaño AG, Naveira AB, Choyke PL.
Novel oncologic drugs: what they do and how they affect images.
Radiographics. 31: 2059-91, 2011.
120)  Kurdziel KA, Lindenberg L, Choyke PL.
Oncologic Angiogenesis Imaging in the clinic---how and why.
Imaging Med. 3: 445-457, 2011.
121)  Housri N, Ning H, Ondos J, Choyke P, Camphausen K, Citrin D, Arora B, Shankavaram U, Kaushal A.
Parameters favorable to intraprostatic radiation dose escalation in men with localized prostate cancer.
Int. J. Radiat. Oncol. Biol. Phys. 80: 614-20, 2011.
122)  Bouchelouche K, Tagawa ST, Goldsmith SJ, Turkbey B, Capala J, Choyke P.
PET/CT Imaging and Radioimmunotherapy of Prostate Cancer.
Semin Nucl Med. 41: 29-44, 2011.
123)  Kummar S, Gutierrez ME, Chen A, Turkbey IB, Allen D, Horneffer YR, Juwara L, Cao L, Yu Y, Kim YS, Trepel J, Chen H, Choyke P, Melillo G, Murgo AJ, Collins J, Doroshow JH.
Phase I trial of vandetanib and bevacizumab evaluating the VEGF and EGF signal transduction pathways in adults with solid tumours and lymphomas.
Eur. J. Cancer. 47: 997-1005, 2011.
124)  Daar D, Bernardo M, Choyke PL, McKinney Y, Turkbey B.
Prostate multiparameter MR imaging.
Radiol Technol. 82: 563MR-8MR, 2011.
125)  Urano Y, Sakabe M, Kosaka N, Ogawa M, Mitsunaga M, Asanuma D, Kamiya M, Young MR, Nagano T, Choyke PL, Kobayashi H.
Rapid cancer detection by topically spraying a γ-glutamyltranspeptidase-activated fluorescent probe.
Sci Transl Med. 3: 110ra119, 2011.
126)  Kobayashi H, Longmire MR, Ogawa M, Choyke PL.
Rational chemical design of the next generation of molecular imaging probes based on physics and biology: mixing modalities, colors and signals.
Chem Soc Rev. [Epub ahead of print], 2011.
127)  Choyke PL.
Science to practice: angiogenic marker expression during tumor growth--can targeted US microbubbles help monitor molecular changes in the microvasculature?.
Radiology. 258: 655-6, 2011.
128)  Choyke PL.
Science to Practice: Pilot Study of FPPRGD2 for Imaging {alpha}v{beta}3 Integrin--How Integral Are Integrins?.
Radiology. 260: 1-2, 2011.
129)  Cao Y, Yuan Y, Li X, Turkbey B, Choyke PL, Yan P.
Segmenting images by combining selected atlases on manifold.
Med Image Comput Comput Assist Interv. 14: 272-9, 2011.
130)  Kobayashi H, Choyke PL.
Target-cancer-cell-specific activatable fluorescence imaging probes: rational design and in vivo applications.
Acc. Chem. Res. 44: 83-90, 2011.
131)  Nakajima T, Mitsunaga M, Bander NH, Heston WD, Choyke PL, Kobayashi H.
Targeted, Activatable, In Vivo Fluorescence Imaging of Prostate-specific Membrane Antigen (PSMA)-positive Tumors Using the Quenched Humanized J591 Antibody-ICG Conjugate.
Bioconjug Chem. [Epub ahead of print], 2011.
132)  Chen L, Choyke PL, Chan TH, Chi CY, Wang G, Wang Y.
Tissue-specific compartmental analysis for dynamic contrast-enhanced MR imaging of complex tumors.
IEEE Trans Med Imaging. 30: 2044-58, 2011.
133)  Kakareka JW, McCann TE, Kosaka N, Mitsunaga M, Morgan NY, Pohida TJ, Choyke PL, Kobayashi H.
A Portable Fluorescence Camera for Testing Surgical Specimens in the Operating Room: Description and Early Evaluation.
Mol Imaging Biol. [Epub ahead of print], 2010.
134)  McCann TE, Kosaka N, Mitsunaga M, Choyke PL, Gildersleeve JC, Kobayashi H.
Biodistribution and excretion of monosaccharide-albumin conjugates measured with in vivo near-infrared fluorescence imaging.
Bioconjug. Chem. 21: 1925-32, 2010.
135)  Gunay-Aygun M, Font-Montgomery E, Lukose L, Tuchman M, Graf J, Bryant JC, Kleta R, Garcia A, Edwards H, Piwnica-Worms K, Adams D, Bernardini I, Fischer RE, Krasnewich D, Oden N, Ling A, Quezado Z, Zak C, Daryanani KT, Turkbey B, Choyke P, Guay-Woodford LM, Gahl WA.
Correlation of kidney function, volume and imaging findings, and PKHD1 mutations in 73 patients with autosomal recessive polycystic kidney disease.
Clin J Am Soc Nephrol. 5: 972-84, 2010.
136)  Turkbey B, Xu S, Kruecker J, Locklin J, Pang Y, Bernardo M, Merino MJ, Wood BJ, Choyke PL, Pinto PA.
Documenting the location of prostate biopsies with image fusion.
BJU Int. 107: 53-7, 2010.
137)  Alford R, Ogawa M, Hassan M, Gandjbakhche AH, Choyke PL, Kobayashi H.
Fluorescence lifetime imaging of activatable target specific molecular probes.
Contrast Media Mol Imaging. 5: 1-8, 2010.
138)  Ogawa M, Kosaka N, Regino CA, Mitsunaga M, Choyke PL, Kobayashi H.
High sensitivity detection of cancer in vivo using a dual-controlled activation fluorescent imaging probe based on H-dimer formation and pH activation.
Mol Biosyst. 6: 888-93, 2010.
139)  Bouchelouche K, Turkbey B, Choyke P, Capala J.
Imaging prostate cancer: an update on positron emission tomography and magnetic resonance imaging.
Curr Urol Rep. 11: 180-90, 2010.
140)  Rosenblum LT, Kosaka N, Mitsunaga M, Choyke PL, Kobayashi H.
In vivo molecular imaging using nanomaterials: General in vivo characteristics of nano-sized reagents and applications for cancer diagnosis (Review).
Mol Membr Biol. 27: 274-85, 2010.
141)  Bumb A, Brechbiel MW, Choyke P.
Macromolecular and dendrimer-based magnetic resonance contrast agents.
Acta Radiol. 51: 751-67, 2010.
142)  Sena LM, Fishman SJ, Jenkins KJ, Xu H, Brechbiel MW, Regino CA, Kosaka N, Bernardo M, Choyke PL, Kobayashi H.
Magnetic resonance lymphangiography with a nano-sized gadolinium-labeled dendrimer in small and large animal models.
Nanomedicine. 5: 1183-91, 2010.
143)  McCann TE, Kosaka N, Turkbey B, Mitsunaga M, Choyke PL, Kobayashi H.
Molecular imaging of tumor invasion and metastases: the role of MRI.
NMR Biomed. [Epub ahead of print], 2010.
144)  Xi W, Seidel J, Kakareka JW, Pohida TJ, Milenic DE, Proffitt J, Majewski S, Weisenberger AG, Green MV, Choyke PL.
MONICA: a compact, portable dual gamma camera system for mouse whole-body imaging.
Nucl. Med. Biol. 37: 245-53, 2010.
145)  Kobayashi H, Longmire MR, Ogawa M, Choyke PL, Kawamoto S.
Multiplexed imaging in cancer diagnosis: applications and future advances.
Lancet Oncol. 11: 589-595, 2010.
146)  Ogawa M, Regino CA, Marcelino B, Williams M, Kosaka N, Bryant LH, Choyke PL, Kobayashi H.
New nanosized biocompatible MR contrast agents based on lysine-dendri-graft macromolecules.
Bioconjug. Chem. 21: 955-60, 2010.
147)  Kobayashi H, Ogawa M, Alford R, Choyke PL, Urano Y.
New strategies for fluorescent probe design in medical diagnostic imaging.
Chem. Rev. 110: 2620-40, 2010.
148)  Rosenblum LT, Kosaka N, Mitsunaga M, Choyke PL, Kobayashi H.
Optimizing quantitative in vivo fluorescence imaging with near-infrared quantum dots.
Contrast Media Mol Imaging. 6: 148-52, 2010.
149)  Bumb A, Regino CA, Perkins MR, Bernardo M, Ogawa M, Fugger L, Choyke PL, Dobson PJ, Brechbiel MW.
Preparation and characterization of a magnetic and optical dual-modality molecular probe.
Nanotechnology. 21: 175704, 2010.
150)  Turkbey B, Pinto PA, Mani H, Bernardo M, Pang Y, McKinney YL, Khurana K, Ravizzini GC, Albert PS, Merino MJ, Choyke PL.
Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation.
Radiology. 255: 89-99, 2010.
151)  Verma S, Rajesh A, Fütterer JJ, Turkbey B, Scheenen TW, Pang Y, Choyke PL, Kurhanewicz J.
Prostate MRI and 3D MR spectroscopy: how we do it.
AJR Am J Roentgenol. 194: 1414-26, 2010.
152)  Bouchelouche K, Choyke PL, Capala J.
Prostate specific membrane antigen- a target for imaging and therapy with radionuclides.
Discov Med. 9: 55-61, 2010.
153)  Kosaka N, McCann TE, Mitsunaga M, Choyke PL, Kobayashi H.
Real-time optical imaging using quantum dot and related nanocrystals.
Nanomedicine. 5: 765-76, 2010.
154)  Kosaka N, Mitsunaga M, Bhattacharyya S, Miller SC, Choyke PL, Kobayashi H.
Self-illuminating in vivo lymphatic imaging using a bioluminescence resonance energy transfer quantum dot nano-particle.
Contrast Media Mol Imaging. 6: 55-9, 2010.
155)  Kosaka N, Ogawa M, Paik DS, Paik CH, Choyke PL, Kobayashi H.
Semiquantitative assessment of the microdistribution of fluorescence-labeled monoclonal antibody in small peritoneal disseminations of ovarian cancer.
Cancer Sci. 101: 820-5, 2010.
156)  Bumb A, Regino CA, Egen JG, Bernardo M, Dobson PJ, Germain RN, Choyke PL, Brechbiel MW.
Trafficking of a Dual-Modality Magnetic Resonance and Fluorescence Imaging Superparamagnetic Iron Oxide-Based Nanoprobe to Lymph Nodes.
Mol Imaging Biol. [Epub ahead of print], 2010.
157)  Regino CA, Ogawa M, Alford R, Wong KJ, Kosaka N, Williams M, Feild BJ, Takahashi M, Choyke PL, Kobayashi H.
Two-step synthesis of galactosylated human serum albumin as a targeted optical imaging agent for peritoneal carcinomatosis.
J. Med. Chem. 53: 1579-86, 2010.
158)  Annunziata CM, Walker AJ, Minasian L, Yu M, Kotz H, Wood BJ, Calvo K, Choyke P, Kimm D, Steinberg SM, Kohn EC.
Vandetanib, designed to inhibit VEGFR2 and EGFR signaling, had no clinical activity as monotherapy for recurrent ovarian cancer and no detectable modulation of VEGFR2.
Clin. Cancer Res. 16: 664-72, 2010.
159)  Shah V, Pohida T, Turkbey B, Mani H, Merino M, Pinto PA, Choyke P, Bernardo M.
A method for correlating in vivo prostate magnetic resonance imaging and histopathology using individualized magnetic resonance-based molds.
Rev Sci Instrum. 80: 104301, 2009.
160)  Turkbey B, Ocak I, Daryanani K, Font-Montgomery E, Lukose L, Bryant J, Tuchman M, Mohan P, Heller T, Gahl WA, Choyke PL, Gunay-Aygun M.
Autosomal recessive polycystic kidney disease and congenital hepatic fibrosis (ARPKD/CHF).
Pediatr Radiol. 39: 100-11, 2009.
161)  Choyke PL.
Can imaging gene expression in human mesenchymal stem cells be successful in large animals?.
Radiology. 252: 1-3, 2009.
162)  Kelloff GJ, Choyke P, Coffey DS.
Challenges in clinical prostate cancer: role of imaging.
AJR Am J Roentgenol. 192: 1455-70, 2009.
163)  Kosaka N, Ogawa M, Choyke PL, Kobayashi H.
Clinical implications of near-infrared fluorescence imaging in cancer.
Future Oncol. 5: 1501-11, 2009.
164)  Choyke PL.
Commentary on.
AJR. American journal of roentgenology. 192: 568-70, 2009.
165)  Mehndiratta A, Knopp MV, Zechmann CM, Owsijewitsch M, von Tengg-Kobligk H, Zamecnik P, Kauczor HU, Choyke PL, Giesel FL.
Comparison of diagnostic quality and accuracy in color-coded versus gray-scale DCE-MR imaging display.
Int J Comput Assist Radiol Surg. 4: 457-62, 2009.
166)  Barrett T, Ravizzini G, Choyke PL, Kobayashi H.
Dendrimers in medical nanotechnology.
IEEE engineering in medicine and biology magazine : the quarterly magazine of the Engineering in Medicine & Biology Society. 28: 12-22, 2009.
167)  Padhani AR, Liu G, Koh DM, Chenevert TL, Thoeny HC, Takahara T, Dzik-Jurasz A, Ross BD, Van Cauteren M, Collins D, Hammoud DA, Rustin GJ, Taouli B, Choyke PL.
Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations.
Neoplasia. 11: 102-25, 2009.
168)  Ogawa M, Regino CA, Seidel J, Green MV, Xi W, Williams M, Kosaka N, Choyke PL, Kobayashi H.
Dual-modality molecular imaging using antibodies labeled with activatable fluorescence and a radionuclide for specific and quantitative targeted cancer detection.
Bioconjug. Chem. 20: 2177-84, 2009.
169)  Ogawa M, Kosaka N, Longmire MR, Urano Y, Choyke PL, Kobayashi H.
Fluorophore-quencher based activatable targeted optical probes for detecting in vivo cancer metastases.
Mol. Pharm. 6: 386-95, 2009.
170)  Ogawa M, Kosaka N, Longmire MR, Urano Y, Choyke PL, Kobayashi H.
Fluorophore-Quencher Based Activatable Targeted Optical Probes for Detecting in Vivo Cancer Metastases.
Mol. Pharm. 2009.
171)  Ogawa M, Kosaka N, Choyke PL, Kobayashi H.
H-Type Dimer Formation of Fluorophores: A Mechanism for Activatable, in Vivo Optical Molecular Imaging.
ACS Chem. Biol. 2009.
172)  Mukherjee S, Richardson AM, Rodriguez-Canales J, Ylaya K, Erickson HS, Player A, Kawasaki ES, Pinto PA, Choyke PL, Merino MJ, Albert PS, Chuaqui RF, Emmert-Buck MR.
Identification of EpCAM as a molecular target of prostate cancer stroma.
Am. J. Pathol. 175: 2277-87, 2009.
173)  Giesel FL, Mehndiratta A, Locklin J, McAuliffe MJ, White S, Choyke PL, Knopp MV, Wood BJ, Haberkorn U, von Tengg-Kobligk H.
Image fusion using CT, MRI and PET for treatment planning, navigation and follow up in percutaneous RFA.
Exp. Oncol. 31: 106-14, 2009.
174)  Turkbey B, Albert PS, Kurdziel K, Choyke PL.
Imaging localized prostate cancer: current approaches and new developments.
Am J Roentgenol. 192: 1471-80, 2009.
175)  Turkbey B, Kobayashi H, Ogawa M, Bernardo M, Choyke PL.
Imaging of tumor angiogenesis: functional or targeted?.
AJR Am J Roentgenol. 193: 304-13, 2009.
176)  Turkbey B, Pinto PA, Choyke PL.
Imaging techniques for prostate cancer: implications for focal therapy.
Nat Rev Urol. 6: 191-203, 2009.
177)  Ogawa M, Kosaka N, Choyke PL, Kobayashi H.
In vivo molecular imaging of cancer with a quenching near-infrared fluorescent probe using conjugates of monoclonal antibodies and indocyanine green.
Cancer Res. 69: 1268-72, 2009.
178)  Kosaka N, Ogawa M, Sato N, Choyke PL, Kobayashi H.
In Vivo Real-Time, Multicolor, Quantum Dot Lymphatic Imaging.
J. Invest. Dermatol. 2009.
179)  Kosaka N, Ogawa M, Choyke PL, Karassina N, Corona C, McDougall M, Lynch DT, Hoyt CC, Levenson RM, Los GV, Kobayashi H.
In Vivo Stable Tumor-Specific Painting in Various Colors Using Dehalogenase-Based Protein-Tag Fluorescent Ligands.
Bioconjug. Chem. 2009.
180)  Ogawa M, Regino CA, Choyke PL, Kobayashi H.
In vivo target-specific activatable near-infrared optical labeling of humanized monoclonal antibodies.
Mol. Cancer Ther. 8: 232-9, 2009.
181)  Gunay-Aygun M, Parisi MA, Doherty D, Tuchman M, Tsilou E, Kleiner DE, Huizing M, Turkbey B, Choyke P, Guay-Woodford L, Heller T, Szymanska K, Johnson CA, Glass I, Gahl WA.
MKS3-related ciliopathy with features of autosomal recessive polycystic kidney disease, nephronophthisis, and Joubert Syndrome.
J. Pediatr. 155: 386-92.e1, 2009.
182)  Alford R, Ogawa M, Choyke PL, Kobayashi H.
Molecular probes for the in vivo imaging of cancer.
Mol Biosyst. 5: 1279-91, 2009.
183)  Young MR, Ileva LV, Bernardo M, Riffle LA, Jones YL, Kim YS, Colburn NH, Choyke PL.
Monitoring of tumor promotion and progression in a mouse model of inflammation-induced colon cancer with magnetic resonance colonography.
Neoplasia. 11: 237-46, 1p following 246, 2009.
184)  Kosaka N, Ogawa M, Longmire MR, Choyke PL, Kobayashi H.
Multi-targeted multi-color in vivo optical imaging in a model of disseminated peritoneal ovarian cancer.
Journal of biomedical optics. 14: 014023, 2009.
185)  Kobayashi H, Ogawa M, Kosaka N, Choyke PL, Urano Y.
Multicolor imaging of lymphatic function with two nanomaterials: quantum dot-labeled cancer cells and dendrimer-based optical agents.
Nanomedicine (London, England). 4: 411-9, 2009.
186)  Longmire M, Kosaka N, Ogawa M, Choyke PL, Kobayashi H.
Multicolor in vivo targeted imaging to guide real-time surgery of HER2-positive micrometastases in a two-tumor coincident model of ovarian cancer.
Cancer Sci. 100: 1099-104, 2009.
187)  Ravizzini G, Turkbey B, Barrett T, Kobayashi H, Choyke PL.
Nanoparticles in sentinel lymph node mapping.
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 1: 610-23, 2009.
188)  Lucarelli RT, Ogawa M, Kosaka N, Turkbey B, Kobayashi H, Choyke PL.
New approaches to lymphatic imaging.
Lymphat Res Biol. 7: 205-14, 2009.
189)  Ravizzini G, Turkbey B, Kurdziel K, Choyke PL.
New horizons in prostate cancer imaging.
European journal of radiology. 70: 212-26, 2009.
190)  Martiniova L, Kotys MS, Thomasson D, Schimel D, Lai EW, Bernardo M, Merino MJ, Powers JF, Ruzicka J, Kvetnansky R, Choyke PL, Pacak K.
Noninvasive monitoring of a murine model of metastatic pheochromocytoma: a comparison of contrast-enhanced microCT and nonenhanced MRI.
Journal of magnetic resonance imaging : JMRI. 29: 685-91, 2009.
191)  Regino CA, Wong KJ, Milenic DE, Holmes EH, Garmestani K, Choyke PL, Brechbiel MW.
Preclinical evaluation of a monoclonal antibody (3C6) specific for prostate-specific membrane antigen.
Current radiopharmaceuticals. 2: 9-17, 2009.
192)  Meister M, Choyke P, Anderson C, Patel U.
Radiological evaluation, management, and surveillance of renal masses in Von Hippel-Lindau disease.
Clin Radiol. 64: 589-600, 2009.
193)  Choudhary S, Sudarshan S, Choyke PL, Prasad SR.
Renal cell carcinoma: recent advances in genetics and imaging.
Semin. Ultrasound CT MR. 30: 315-25, 2009.
194)  Urano Y, Asanuma D, Hama Y, Koyama Y, Barrett T, Kamiya M, Nagano T, Watanabe T, Hasegawa A, Choyke PL, Kobayashi H.
Selective molecular imaging of viable cancer cells with pH-activatable fluorescence probes.
Nat. Med. 15: 104-9, 2009.
195)  Turkbey B, Thomasson D, Pang Y, Bernardo M, Choyke PL.
The role of dynamic contrast-enhanced MRI in cancer diagnosis and treatment.
Diagnostic and interventional radiology (Ankara, Turkey). 2009.
196)  Xu H, Eck PK, Baidoo KE, Choyke PL, Brechbiel MW.
Toward preparation of antibody-based imaging probe libraries for dual-modality positron emission tomography and fluorescence imaging.
Bioorg. Med. Chem. 2009.
197)  Alford R, Simpson HM, Duberman J, Hill GC, Ogawa M, Regino C, Kobayashi H, Choyke PL.
Toxicity of organic fluorophores used in molecular imaging: literature review.
Mol Imaging. 8: 341-54, 2009.
198)  Ogawa M, Kosaka N, Choyke PL, Kobayashi H.
Tumor-specific detection of an optically targeted antibody combined with a quencher-conjugated neutravidin.
Bioconjug. Chem. 20: 147-54, 2009.
199)  Regino CA, Walbridge S, Bernardo M, Wong KJ, Johnson D, Lonser R, Oldfield EH, Choyke PL, Brechbiel MW.
A dual CT-MR dendrimer contrast agent as a surrogate marker for convection-enhanced delivery of intracerebral macromolecular therapeutic agents.
Contrast media & molecular imaging. 3: 2-8, 2008.
200)  Toro JR, Wei MH, Glenn GM, Weinreich M, Toure O, Vocke C, Turner M, Choyke P, Merino MJ, Pinto PA, Steinberg SM, Schmidt LS, Linehan WM.
BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dubé syndrome: a new series of 50 families and a review of published reports.
J. Med. Genet. 45: 321-31, 2008.
201)  Longmire M, Choyke PL, Kobayashi H.
Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats.
Nanomedicine (London, England). 3: 703-17, 2008.
202)  Longmire M, Choyke PL, Kobayashi H.
Dendrimer-based contrast agents for molecular imaging.
Current topics in medicinal chemistry. 8: 1180-6, 2008.
203)  Longmire MR, Ogawa M, Hama Y, Kosaka N, Regino CA, Choyke PL, Kobayashi H.
Determination of optimal rhodamine fluorophore for in vivo optical imaging.
Bioconjug. Chem. 19: 1735-42, 2008.
204)  Segarra M, Williams CK, Sierra Mde L, Bernardo M, McCormick PJ, Maric D, Regino C, Choyke P, Tosato G.
Dll4 activation of Notch signaling reduces tumor vascularity and inhibits tumor growth.
Blood. 112: 1904-11, 2008.
205)  Singh AK, Kruecker J, Xu S, Glossop N, Guion P, Ullman K, Choyke PL, Wood BJ.
Initial clinical experience with real-time transrectal ultrasonography-magnetic resonance imaging fusion-guided prostate biopsy.
BJU Int. 101: 841-5, 2008.
206)  Baba M, Furihata M, Hong SB, Tessarollo L, Haines DC, Southon E, Patel V, Igarashi P, Alvord WG, Leighty R, Yao M, Bernardo M, Ileva L, Choyke P, Warren MB, Zbar B, Linehan WM, Schmidt LS.
Kidney-targeted Birt-Hogg-Dube gene inactivation in a mouse model: Erk1/2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneys.
J. Natl. Cancer Inst. 100: 140-54, 2008.
207)  Singh AK, Krieger A, Lattouf JB, Guion P, Grubb RL, Albert PS, Metzger G, Ullman K, Smith S, Fichtinger G, Ocak I, Choyke P, Ménard C, Coleman J.
Patient selection determines the prostate cancer yield of dynamic contrast-enhanced magnetic resonance imaging-guided transrectal biopsies in a closed 3-Tesla scanner.
BJU Int. 101: 181-5, 2008.
208)  Giesel FL, Choyke PL, Mehndiratta A, Zechmann CM, von Tengg-Kobligk H, Kayser K, Bischoff H, Hintze C, Delorme S, Weber MA, Essig M, Kauczor HU, Knopp MV.
Pharmacokinetic analysis of malignant pleural mesothelioma-initial results of tumor microcirculation and its correlation to microvessel density (CD-34).
Academic radiology. 15: 563-70, 2008.
209)  Choyke PL.
Radiologic evaluation of hematuria: guidelines from the American College of Radiology's appropriateness criteria.
American family physician. 78: 347-52, 2008.
210)  Xu S, Kruecker J, Turkbey B, Glossop N, Singh AK, Choyke P, Pinto P, Wood BJ.
Real-time MRI-TRUS fusion for guidance of targeted prostate biopsies.
Comput. Aided Surg. 13: 255-64, 2008.
211)  Bratslavsky G, Liu JJ, Johnson AD, Sudarshan S, Choyke PL, Linehan WM, Pinto PA.
Salvage partial nephrectomy for hereditary renal cancer: feasibility and outcomes.
J. Urol. 179: 67-70, 2008.
212)  Bumb A, Brechbiel MW, Choyke PL, Fugger L, Eggeman A, Prabhakaran D, Hutchinson J, Dobson PJ.
Synthesis and characterization of ultra-small superparamagnetic iron oxide nanoparticles thinly coated with silica.
Nanotechnology. 19: 335601, 2008.
213)  Boswell CA, Eck PK, Regino CA, Bernardo M, Wong KJ, Milenic DE, Choyke PL, Brechbiel MW.
Synthesis, characterization, and biological evaluation of integrin alphavbeta3-targeted PAMAM dendrimers.
Mol. Pharm. 5: 527-39, 2008.
214)  Kurdziel K, Ravizzini G, Croft B, Tatum J, Choyke P, Kobayashi H.
The evolving role of nuclear molecular imaging in cancer.
Expert opinion on medical diagnostics. 2: 829-842, 2008.
215)  Koyama Y, Talanov VS, Bernardo M, Hama Y, Regino CA, Brechbiel MW, Choyke PL, Kobayashi H.
A dendrimer-based nanosized contrast agent dual-labeled for magnetic resonance and optical fluorescence imaging to localize the sentinel lymph node in mice.
Journal of magnetic resonance imaging : JMRI. 25: 866-71, 2007.
216)  Mai PL, Korde L, Kramer J, Peters J, Mueller CM, Pfeiffer S, Stratakis CA, Pinto PA, Bratslavsky G, Merino M, Choyke P, Linehan WM, Greene MH.
A possible new syndrome with growth-hormone secreting pituitary adenoma, colonic polyposis, lipomatosis, lentigines and renal carcinoma in association with familial testicular germ cell malignancy: A case report.
Journal of medical case reports. 1: 9, 2007.
217)  Hama Y, Urano Y, Koyama Y, Gunn AJ, Choyke PL, Kobayashi H.
A self-quenched galactosamine-serum albumin-rhodamineX conjugate: a.
Clin. Cancer Res. 13: 6335-43, 2007.
218)  Hama Y, Urano Y, Koyama Y, Kamiya M, Bernardo M, Paik RS, Shin IS, Paik CH, Choyke PL, Kobayashi H.
A target cell-specific activatable fluorescence probe for in vivo molecular imaging of cancer based on a self-quenched avidin-rhodamine conjugate.
Cancer Res. 67: 2791-9, 2007.
219)  Hama Y, Urano Y, Koyama Y, Choyke PL, Kobayashi H.
Activatable Fluorescent Molecular Imaging of Peritoneal Metastases following Pretargeting with a Biotinylated Monoclonal Antibody.
Cancer Res. 67: 3809-17, 2007.
220)  Kamiya M, Kobayashi H, Hama Y, Koyama Y, Bernardo M, Nagano T, Choyke PL, Urano Y.
An enzymatically activated fluorescence probe for targeted tumor imaging.
J. Am. Chem. Soc. 129: 3918-29, 2007.
221)  Chen Q, Espey MG, Sun AY, Lee JH, Krishna MC, Shacter E, Choyke PL, Pooput C, Kirk KL, Buettner GR, Levine M.
Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo.
Proc. Natl. Acad. Sci. U.S.A. 104: 8749-54, 2007.
222)  Blansfield JA, Choyke L, Morita SY, Choyke PL, Pingpank JF, Alexander HR, Seidel G, Shutack Y, Yuldasheva N, Eugeni M, Bartlett DL, Glenn GM, Middelton L, Linehan WM, Libutti SK.
Clinical, genetic and radiographic analysis of 108 patients with von Hippel-Lindau disease (VHL) manifested by pancreatic neuroendocrine neoplasms (PNETs).
Surgery. 142: 814-8; discussion 818.e1-2, 2007.
223)  Xu S, Kruecker J, Guion P, Glossop N, Neeman Z, Choyke P, Singh AK, Wood BJ.
Closed-loop control in fused MR-TRUS image-guided prostate biopsy.
Med Image Comput Comput Assist Interv. 10: 128-35, 2007.
224)  de Souza LR, Goldman SM, Faintuch S, Faria JF, Bekhor D, Tiferes DA, Ortiz V, Choyke P, Szejnfeld J.
Comparison between ultrasound and noncontrast helical computed tomography for identification of acute ureterolithiasis in a teaching hospital setting.
São Paulo medical journal = Revista paulista de medicina. 125: 102-7, 2007.
225)  Hama Y, Urano Y, Koyama Y, Choyke PL, Kobayashi H.
D-galactose receptor-targeted in vivo spectral fluorescence imaging of peritoneal metastasis using galactosamin-conjugated serum albumin-rhodamine green.
Journal of biomedical optics. 12: 051501, 2007.
226)  Xu H, Baidoo K, Gunn AJ, Boswell CA, Milenic DE, Choyke PL, Brechbiel MW.
Design, Synthesis, and Characterization of a Dual Modality Positron Emission Tomography and Fluorescence Imaging Agent for Monoclonal Antibody Tumor-Targeted Imaging.
J Med Chem. 2007.
227)  Ocak I, Bernardo M, Metzger G, Barrett T, Pinto P, Albert PS, Choyke PL.
Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters.
AJR. American journal of roentgenology. 189: 849, 2007.
228)  Zbar B, Glenn G, Merino M, Middelton L, Peterson J, Toro J, Coleman J, Pinto P, Schmidt LS, Choyke P, Linehan WM.
Familial renal carcinoma: clinical evaluation, clinical subtypes and risk of renal carcinoma development.
J. Urol. 177: 461-5; discussion 465, 2007.
229)  Roberts JN, Buck CB, Thompson CD, Kines R, Bernardo M, Choyke PL, Lowy DR, Schiller JT.
Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan.
Nat. Med. 13: 857-61, 2007.
230)  Hussain N, Feld JJ, Kleiner DE, Hoofnagle JH, Garcia-Eulate R, Ahlawat S, Koziel DE, Anderson V, Hilligoss D, Choyke P, Gallin JI, Liang TJ, Malech HL, Holland SM, Heller T.
Hepatic abnormalities in patients with chronic granulomatous disease.
Hepatology. 45: 675-83, 2007.
231)  Grubb RL, Franks ME, Toro J, Middelton L, Choyke L, Fowler S, Torres-Cabala C, Glenn GM, Choyke P, Merino MJ, Zbar B, Pinto PA, Srinivasan R, Coleman JA, Linehan WM.
Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer.
J. Urol. 177: 2074-9; discussion 2079-80, 2007.
232)  Linehan WM, Pinto PA, Srinivasan R, Merino M, Choyke P, Choyke L, Coleman J, Toro J, Glenn G, Vocke C, Zbar B, Schmidt LS, Bottaro D, Neckers L.
Identification of the genes for kidney cancer: opportunity for disease-specific targeted therapeutics.
Clin. Cancer Res. 13: 671s-679s, 2007.
233)  Hricak H, Choyke PL, Eberhardt SC, Leibel SA, Scardino PT.
Imaging prostate cancer: a multidisciplinary perspective.
Radiology. 243: 28-53, 2007.
234)  Barrett T, Koyama Y, Hama Y, Ravizzini G, Shin IS, Jang BS, Paik CH, Urano Y, Choyke PL, Kobayashi H.
In vivo diagnosis of epidermal growth factor receptor expression using molecular imaging with a cocktail of optically labeled monoclonal antibodies.
Clin. Cancer Res. 13: 6639-48, 2007.
235)  Koyama Y, Barrett T, Hama Y, Ravizzini G, Choyke PL, Kobayashi H.
In vivo molecular imaging to diagnose and subtype tumors through receptor-targeted optically labeled monoclonal antibodies.
Neoplasia. 9: 1021-9, 2007.
236)  Thukral A, Thomasson DM, Chow CK, Eulate R, Wedam SB, Gupta SN, Wise BJ, Steinberg SM, Liewehr DJ, Choyke PL, Swain SM.
Inflammatory Breast Cancer: Dynamic Contrast-enhanced MR in Patients Receiving Bevacizumab Initial Experience.
Radiology. 244: 727-35, 2007.
237)  Choyke PL.
Is it possible to quantify fluorescence during optical endoscopy?.
Radiology. 245: 307-8, 2007.
238)  Toro JR, Pautler SE, Stewart L, Glenn GM, Weinreich M, Toure O, Wei MH, Schmidt LS, Davis L, Zbar B, Choyke P, Steinberg SM, Nguyen DM, Linehan WM.
Lung cysts, spontaneous pneumothorax, and genetic associations in 89 families with Birt-Hogg-Dubé syndrome.
Am. J. Respir. Crit. Care Med. 175: 1044-53, 2007.
239)  Lattouf JB, Grubb RL, Lee SJ, Bjurlin MA, Albert P, Singh AK, Ocak I, Choyke P, Coleman JA.
Magnetic resonance imaging-directed transrectal ultrasonography-guided biopsies in patients at risk of prostate cancer.
BJU Int. 99: 1041-6, 2007.
240)  Hama Y, Bernardo M, Regino CA, Koyama Y, Brechbiel MW, Krishna MC, Choyke PL, Kobayashi H.
MR lymphangiography using dendrimer-based contrast agents: a comparison at 1.5T and 3.0T.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 57: 431-6, 2007.
241)  Barrett T, Brechbiel M, Bernardo M, Choyke PL.
MRI of tumor angiogenesis.
Journal of magnetic resonance imaging : JMRI. 26: 235-49, 2007.
242)  Kobayashi H, Koyama Y, Barrett T, Hama Y, Regino CA, Shin IS, Jang BS, Le N, Paik CH, Choyke PL, Urano Y.
Multimodal nanoprobes for radionuclide and five-color near-infrared optical lymphatic imaging.
ACS Nano. 1: 258-64, 2007.
243)  Xu H, Regino CA, Koyama Y, Hama Y, Gunn AJ, Bernardo M, Kobayashi H, Choyke PL, Brechbiel MW.
Preparation and Preliminary Evaluation of a Biotin-Targeted, Lectin-Targeted Dendrimer-Based Probe for Dual-Modality Magnetic Resonance and Fluorescence Imaging.
Bioconjug Chem. 2007.
244)  Singh AK, Guion P, Sears-Crouse N, Ullman K, Smith S, Albert PS, Fichtinger G, Choyke PL, Xu S, Kruecker J, Wood BJ, Krieger A, Ning H.
Simultaneous integrated boost of biopsy proven, MRI defined dominant intra-prostatic lesions to 95 Gray with IMRT: early results of a phase I NCI study.
Radiation oncology (London, England). 2: 36, 2007.
245)  Kobayashi H, Hama Y, Koyama Y, Barrett T, Regino CA, Urano Y, Choyke PL.
Simultaneous multicolor imaging of five different lymphatic basins using quantum dots.
Nano Lett. 7: 1711-6, 2007.
246)  Koyama Y, Hama Y, Urano Y, Nguyen DM, Choyke PL, Kobayashi H.
Spectral fluorescence molecular imaging of lung metastases targeting HER2/neu.
Clin. Cancer Res. 13: 2936-45, 2007.
247)  Hama Y, Koyama Y, Bernardo M, Choyke PL, Kobayashi H.
Spectral near-infrared fluorescence imaging of curved surfaces using projection reconstruction algorithms.
Contrast media & molecular imaging. 2: 82-7, 2007.
248)  Gunn AJ, Hama Y, Koyama Y, Kohn EC, Choyke PL, Kobayashi H.
Targeted optical fluorescence imaging of human ovarian adenocarcinoma using a galactosyl serum albumin-conjugated fluorophore.
Cancer Sci. 98: 1727-33, 2007.
249)  Ocak I, Baluk P, Barrett T, McDonald DM, Choyke P.
The biologic basis of in vivo angiogenesis imaging.
Front. Biosci. 12: 3601-16, 2007.
250)  Gunn AJ, Brechbiel MW, Choyke PL.
The emerging role of molecular imaging and targeted therapeutics in peritoneal carcinomatosis.
Expert opinion on drug delivery. 4: 389-402, 2007.
251)  Xu H, Regino CA, Bernardo M, Koyama Y, Kobayashi H, Choyke PL, Brechbiel MW.
Toward improved syntheses of dendrimer-based magnetic resonance imaging contrast agents: new bifunctional diethylenetriaminepentaacetic acid ligands and nonaqueous conjugation chemistry.
J. Med. Chem. 50: 3185-93, 2007.
252)  Gunn AJ, Kobayashi H, Choyke PL.
Tumor-targeted optical imaging in the management of peritoneal carcinomatosis.
South Dakota medicine : the journal of the South Dakota State Medical Association. 60: 353-7, 2007.
253)  Hama Y, Koyama Y, Choyke PL, Kobayashi H.
Two-color in vivo dynamic contrast-enhanced pharmacokinetic imaging.
Journal of biomedical optics. 12: 034016, 2007.
254)  Hama Y, Koyama Y, Urano Y, Choyke PL, Kobayashi H.
Two-Color Lymphatic Mapping Using Ig-Conjugated Near Infrared Optical Probes.
J Invest Dermatol. 2007.
255)  Ferrier MC, Sarin H, Fung SH, Schatlo B, Pluta RM, Gupta SN, Choyke PL, Oldfield EH, Thomasson D, Butman JA.
Validation of dynamic contrast-enhanced magnetic resonance imaging-derived vascular permeability measurements using quantitative autoradiography in the RG2 rat brain tumor model.
Neoplasia. 9: 546-55, 2007.
256)  Hama Y, Koyama Y, Urano Y, Choyke P, Kobayashi H.
A comparison of 4 green fluorophores in vivo.
Bioconjugate Chemistry. in press, 2006.
257)  Hama Y, Urano Y, Koyama Y, Bernardo M, Choyke PL, Kobayashi H.
A comparison of the emission efficiency of four common green fluorescence dyes after internalization into cancer cells.
Bioconjug. Chem. 17: 1426-31, 2006.
258)  Choyke PL.
ACR Appropriateness Criteria(R) on Incidentally Discovered Adrenal Mass.
Journal of the American College of Radiology : JACR. 3: 498-504, 2006.
259)  Wedam SB, Low JA, Yang SX, Chow CK, Choyke P, Danforth D, Hewitt SM, Berman A, Steinberg SM, Liewehr DJ, Plehn J, Doshi A, Thomasson D, McCarthy N, Koeppen H, Sherman M, Zujewski J, Camphausen K, Chen H, Swain SM.
Antiangiogenic and antitumor effects of bevacizuman in inflammatory and locally advanced breast cancer patients.
J Clin Oncol. Jan 3, 2006.
260)  Gunay-Aygun M, Avner ED, Bacallao RL, Choyke PL, Flynn JT, Germino GG, Guay-Woodford L, Harris P, Heller T, Ingelfinger J, Kaskel F, Kleta R, LaRusso NF, Mohan P, Pazour GJ, Shneider BL, Torres VE, Wilson P, Zak C, Zhou J, Gahl WA.
Autosomal recessive polycystic kidney disease and congenital hepatic fibrosis: summary statement of a first National Institutes of Health/Office of Rare Diseases conference.
J. Pediatr. 149: 159-64, 2006.
261)  Garcia-Eulate R, Hussain N, Heller T, Kleiner D, Malech H, Holland S, Choyke PL.
CT and MRI of hepatic abscess in patients with chronic granulomatous disease.
AJR. American journal of roentgenology. 187: 482-90, 2006.
262)  Kobayashi H, Kawamoto S, Bernardo M, Brechbiel MW, Knopp MV, Choyke PL.
Delivery of gadolinium-labeled nanoparticles to the sentinel lymph node: Comparison of the sentinel node visualization and estimations of intra-nodal gadolinium concentration by the magnetic resonance imaging.
J Control Release. 2006.
263)  Talanov VS, Regino CA, Kobayashi H, Bernardo M, Choyke PL, Brechbiel MW.
Dendrimer-based nanoprobe for dual modality magnetic resonance and fluorescence imaging.
Nano Lett. 6: 1459-63, 2006.
264)  Tang JS, Choy G, Bernardo M, Thomasson D, Libutti SK, Choyke PL.
Dynamic contrast-enhanced magnetic resonance imaging in the assessment of early response to tumor necrosis factor alpha in a colon carcinoma model.
Investigative radiology. 41: 691-6, 2006.
265)  Barrett T, Choyke PL, Kobayashi H.
Imaging of the lymphatic system: new horizons.
Contrast media & molecular imaging. 1: 230-45, 2006.
266)  Hama Y, Urano Y, Koyama Y, Kamiya M, Bernardo M, Paik RS, Krishna MC, Choyke PL, Kobayashi H.
In vivo spectral fluorescence imaging of submillimeter peritoneal cancer implants using a lectin-targeted optical agent.
Neoplasia. 8: 607-12, 2006.
267)  Barrett T, Kobayashi H, Brechbiel M, Choyke PL.
Macromolecular MRI contrast agents for imaging tumor angiogenesis.
Eur J Radiol. 2006.
268)  Matsumoto K, Bernardo M, Subramanian S, Choyke P, Mitchell JB, Krishna MC, Lizak MJ.
MR assessment of changes of tumor in response to hyperbaric oxygen treatment.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 56: 240-6, 2006.
269)  Hama Y, Koyama Y, Urano Y, Choyke PL, Kobayashi H.
Simultaneous two-color spectral fluorescence lymphangiography with near infrared quantum dots to map two lymphatic flows from the breast and the upper extremity.
Breast Cancer Res Treat. 2006.
270)  Hama Y, Urano Y, Koyama Y, Choyke PL, Kobayashi H.
Targeted optical imaging of cancer cells using lectin-binding BODIPY conjugated avidin.
Biochem. Biophys. Res. Commun. 348: 807-13, 2006.
271)  Susil RC, Ménard C, Krieger A, Coleman JA, Camphausen K, Choyke P, Fichtinger G, Whitcomb LL, Coleman CN, Atalar E.
Transrectal prostate biopsy and fiducial marker placement in a standard 1.5T magnetic resonance imaging scanner.
J Urol. 175: 113-20, 2006.
272)  Ménard C, Susil RC, Choyke P, Coleman J, Grubb R, Gharib A, Krieger A, Guion P, Thomasson D, Ullman K, Gupta S, Espina V, Liotta L, Petricoin E, Fitchtinger G, Whitcomb LL, Atalar E, Coleman CN, Camphausen K.
An interventional magnetic resonance imaging technique for the molecular characterization of intraprostatic dynamic contrast enhancement.
Molecular Imaging. 4(1): 63-6, 2005.
273)  Choyke PL.
Contrast agents for imaging tumor angiogenesis: is bigger better?.
Radiology. 235: 1-2, 2005.
274)  Zhang Y, Choyke PL, Lu H, Takahashi H, Mannon RB, Zhang X, Marcos H, Li KC, Kopp JB.
Detection and Localization of Proteinuria by Dynamic Contrast-Enhanced Magnetic Resonance Imaging Using MS325.
J Am Soc Nephrol. 16: 1752-7, 2005.
275)  Kobayashi H, Kawamoto S, Brechbiel MW, Bernardo M, Sato N, Waldmann TA, Tagaya Y, Choyke PL.
Detection of lymph node involvement in hematologic malignancies using micromagnetic resonance lymphangiography with a gadolinum-labeled dendrimer nanoparticle.
Neoplasia. 7: 984-91, 2005.
276)  Kobayashi H, Kawamoto S, Brechbiel MW, Bernardo M, Sato N, Waldmann TA, Tagaya Y, Choyke PL.
Detection of lymph node involvement in hematologic malignancies using micromagnetic resonance lymphangiography with a gadolinum-labeled dendrimer nanoparticle.
Neoplasia. Nov;7(11): 984-91, 2005.
277)  Pavlovich CP, Grubb RL, Hurley K, Glenn GM, Toro J, Schmidt LS, Torres-Cabala C, Merino MJ, Zbar B, Choyke P, Walther MM, Linehan WM.
Evaluation and management of renal tumors in the Birt-Hogg-Dube syndrome.
J Urol. 173: 1482-6, 2005.
278)  Choyke PL, Kobayashi H.
Functional magnetic resonance imaging of the kidney using macromolecular contrast agents.
Abdominal imaging. 31: 224-31, 2005.
279)  Choyke PL, Kobayashi H.
Functional magnetic resonance imaging of the kidney using macromolecular contrast agents.
Abdominal Imaging. Nov 10, 2005.
280)  Schmidt LS, Nickerson ML, Warren MB, Glenn GM, Toro JR, Merino MJ, Turner ML, Choyke PL, Sharma N, Peterson J, Morrison P, Maher ER, Walther MM, Zbar B, Linehan WM.
Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dube syndrome.
Am J Hum Genet. 76: 1023-33, 2005.
281)  Grubb RL, Choyke PL, Pinto PA, Linehan WM, Walther MM.
Management of von Hippel-Lindau-associated kidney cancer.
Nat Clin Pract Urol. 2: 248-55, 2005.
282)  Wei MH, Toure O, Glenn GM, Pithukpakorn M, Neckers L, Stolle C, Choyke P, Grubb R, Middelton L, Turner ML, Walther MM, Merino MJ, Zbar B, Linehan WM, Toro JR.
Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer.
J Med Genet. 2005.
283)  Bates SE, Bakke S, Kang M, Robey RW, Zhai S, Thambi P, Chen CC, Patil S, Smith T, Steinberg SM, Merino M, Goldspiel B, Meadows B, Stein WD, Choyke P, Balis F, Figg WD, Fojo T.
A phase I/II study of infusional vinblastine with the P-glycoprotein antagonist valspodar (PSC 833) in renal cell carcinoma.
Clin. Cancer Res. 10: 4724-33, 2004.
284)  Finkelstein SE, Carrasquillo JA, Hoffman JM, Galen B, Choyke P, White DE, Rosenberg SA, Sherry RM.
A prospective analysis of positron emission tomography and conventional imaging for detection of stage IV metastatic melanoma in patients undergoing metastasectomy.
Ann. Surg. Oncol. 11: 731-8, 2004.
285)  Gordeuk VR, Sergueeva AI, Miasnikova GY, Okhotin D, Voloshin Y, Choyke PL, Butman JA, Jedlickova K, Prchal JT, Polyakova LA.
Congenital disorder of oxygen sensing: association of the homozygous Chuvash polycythemia VHL mutation with thrombosis and vascular abnormalities but not tumors.
Blood. 103: 3924-32, 2004.
286)  Schmidt LS, Nickerson ML, Angeloni D, Glenn GM, Walther MM, Albert PS, Warren MB, Choyke PL, Torres-Cabala CA, Merino MJ, Brunet J, Bérez V, Borràs J, Sesia G, Middelton L, Phillips JL, Stolle C, Zbar B, Pautler SE, Linehan WM.
Early onset hereditary papillary renal carcinoma: germline missense mutations in the tyrosine kinase domain of the met proto-oncogene.
J. Urol. 172: 1256-61, 2004.
287)  Yim PJ, Cebral JR, Weaver A, Lutz RJ, Soto O, Vasbinder GB, Ho VB, Choyke PL.
Estimation of the differential pressure at renal artery stenoses.
Magn Reson Med. 51: 969-77, 2004.
288)  Hartman DS, Choyke PL, Hartman MS.
From the RSNA refresher courses: a practical approach to the cystic renal mass.
Radiographics. 24 Suppl 1: S101-15, 2004.
289)  Linehan WM, Vasselli J, Srinivasan R, Walther MM, Merino M, Choyke P, Vocke C, Schmidt L, Isaacs JS, Glenn G, Toro J, Zbar B, Bottaro D, Neckers L.
Genetic basis of cancer of the kidney: disease-specific approaches to therapy.
Clin. Cancer Res. 10: 6282S-9S, 2004.
290)  Kobayashi H, Kawamoto S, Sakai Y, Choyke PL, Star RA, Brechbiel MW, Sato N, Tagaya Y, Morris JC, Waldmann TA.
Lymphatic drainage imaging of breast cancer in mice by micro-magnetic resonance lymphangiography using a nano-size paramagnetic contrast agent.
J. Natl. Cancer Inst. 96: 703-8, 2004.
291)  Kobayashi H, Kawamoto S, Brechbiel MW, Jo SK, Hu X, Yang T, Diwan BA, Waldmann TA, Schnermann J, Choyke PL, Star RA.
Micro-MRI methods to detect renal cysts in mice.
Kidney Int. 65: 1511-6, 2004.
292)  Prince MR, Choyke PL, Knopp MV.
More on pseudohypocalcemia and gadolinium-enhanced MRI.
N. Engl. J. Med. 350: 87-8; author reply 87-8, 2004.
293)  Ho VB, Choyke PL.
MR evaluation of solid renal masses.
Magn Reson Imaging Clin N Am. 12: 413-27, v, 2004.
294)  Ménard C, Susil RC, Choyke P, Gustafson GS, Kammerer W, Ning H, Miller RW, Ullman KL, Sears Crouse N, Smith S, Lessard E, Pouliot J, Wright V, McVeigh E, Coleman CN, Camphausen K.
MRI-guided HDR prostate brachytherapy in standard 1.5T scanner.
Int. J. Radiat. Oncol. Biol. Phys. 59: 1414-23, 2004.
295)  Ries M, Bettis KE, Choyke P, Kopp JB, Austin HA, Brady RO, Schiffmann R.
Parapelvic kidney cysts: a distinguishing feature with high prevalence in Fabry disease.
Kidney Int. 66: 978-82, 2004.
296)  Drachenberg DE, Mena OJ, Choyke PL, Linehan WM, Walther MM.
Parenchymal sparing surgery for central renal tumors in patients with hereditary renal cancers.
J. Urol. 172: 49-53, 2004.
297)  Kobayashi H, Jo SK, Kawamoto S, Yasuda H, Hu X, Knopp MV, Brechbiel MW, Choyke PL, Star RA.
Polyamine dendrimer-based MRI contrast agents for functional kidney imaging to diagnose acute renal failure.
J Magn Reson Imaging. 20: 512-8, 2004.
298)  Jamis-Dow CA, Turner J, Biesecker LG, Choyke PL.
Radiologic manifestations of Proteus syndrome.
Radiographics. 24: 1051-68, 2004.
299)  Susil RC, Camphausen K, Choyke P, McVeigh ER, Gustafson GS, Ning H, Miller RW, Atalar E, Coleman CN, Ménard C.
System for prostate brachytherapy and biopsy in a standard 1.5 T MRI scanner.
Magn Reson Med. 52: 683-7, 2004.
300)  Duffey BG, Choyke PL, Glenn G, Grubb RL, Venzon D, Linehan WM, Walther MM.
The relationship between renal tumor size and metastases in patients with von Hippel-Lindau disease.
J. Urol. 172: 63-5, 2004.
301)  Kobayashi H, Kawamoto S, Star RA, Waldmann TA, Brechbiel MW, Choyke PL.
Activated clearance of a biotinylated macromolecular MRI contrast agent from the blood pool using an avidin chase.
Bioconjug. Chem. 14: 1044-7, 2003.
302)  Kobayashi H, Kawamoto S, Choyke PL, Sato N, Knopp MV, Star RA, Waldmann TA, Tagaya Y, Brechbiel MW.
Comparison of dendrimer-based macromolecular contrast agents for dynamic micro-magnetic resonance lymphangiography.
Magn Reson Med. 50: 758-66, 2003.
303)  Knopp MV, von Tengg-Kobligk H, Choyke PL.
Functional magnetic resonance imaging in oncology for diagnosis and therapy monitoring.
Mol. Cancer Ther. 2: 419-26, 2003.
304)  Marcos HB, Zhang Y, Choyke PL.
Functional studies of the kidney with magnetic resonance imaging.
Methods Mol. Med. 86: 69-77, 2003.
305)  Choyke PL, Dwyer AJ, Knopp MV.
Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging.
J Magn Reson Imaging. 17: 509-20, 2003.
306)  Choyke PL, Glenn GM, Walther MM, Zbar B, Linehan WM.
Hereditary renal cancers.
Radiology. 226: 33-46, 2003.
307)  McDonald DM, Choyke PL.
Imaging of angiogenesis: from microscope to clinic.
Nat. Med. 9: 713-25, 2003.
308)  Choyke PL.
Imaging of hereditary renal cancer.
Radiol. Clin. North Am. 41: 1037-51, 2003.
309)  Yim PJ, Vasbinder GB, Ho VB, Choyke PL.
Isosurfaces as deformable models for magnetic resonance angiography.
IEEE Trans Med Imaging. 22: 875-81, 2003.
310)  Choyke PL, Knopp MV.
Pseudohypocalcemia with MR imaging contrast agents: a cautionary tale.
Radiology. 227: 627-8, 2003.
311)  Cebral JR, Yim PJ, Löhner R, Soto O, Choyke PL.
Blood flow modeling in carotid arteries with computational fluid dynamics and MR imaging.
Acad Radiol. 9: 1286-99, 2002.
312)  Hood MN, Ho VB, Foo TK, Marcos HB, Hess SL, Choyke PL.
High-resolution gadolinium-enhanced 3D MRA of the infrapopliteal arteries. Lessons for improving bolus-chase peripheral MRA.
Magn Reson Imaging. 20: 543-9, 2002.
313)  Pautler SE, Choyke PL, Pavlovich CP, Daryanani K, Walther MM.
Intraoperative ultrasound aids in dissection during laparoscopic partial adrenalectomy.
J. Urol. 168: 1352-5, 2002.
314)  Costouros NG, Lorang D, Zhang Y, Miller MS, Diehn FE, Hewitt SM, Knopp MV, Li KC, Choyke PL, Alexander HR, Libutti SK.
Microarray gene expression analysis of murine tumor heterogeneity defined by dynamic contrast-enhanced MRI.
Mol Imaging. 1: 301-8, 2002.
315)  Foo TK, Ho VB, Marcos HB, Hood MN, Choyke PL.
MR angiography using steady-state free precession.
Magn Reson Med. 48: 699-706, 2002.
316)  Marcos HB, Libutti SK, Alexander HR, Lubensky IA, Bartlett DL, Walther MM, Linehan WM, Glenn GM, Choyke PL.
Neuroendocrine tumors of the pancreas in von Hippel-Lindau disease: spectrum of appearances at CT and MR imaging with histopathologic comparison.
Radiology. 225: 751-8, 2002.
317)  Pavlovich CP, Walther MM, Choyke PL, Pautler SE, Chang R, Linehan WM, Wood BJ.
Percutaneous radio frequency ablation of small renal tumors: initial results.
J. Urol. 167: 10-5, 2002.
318)  Ho VB, Allen SF, Hood MN, Choyke PL.
Renal masses: quantitative assessment of enhancement with dynamic MR imaging.
Radiology. 224: 695-700, 2002.
319)  Choyke PL, Knopp MV, Libutti SK.
Special techniques for imaging blood flow to tumors.
Cancer J. 8: 109-18, 2002.
320)  Feldman AL, Alexander HR, Bartlett DL, Kranda KC, Miller MS, Costouros NG, Choyke PL, Libutti SK.
A prospective analysis of plasma endostatin levels in colorectal cancer patients with liver metastases.
Ann. Surg. Oncol. 8: 741-5, 2001.
321)  Ho VB, Foo TK, Czum JM, Marcos H, Choyke PL, Knopp MV.
Contrast-enhanced magnetic resonance angiography: technical considerations for optimized clinical implementation.
Top Magn Reson Imaging. 12: 283-99, 2001.
322)  Choyke PL, Yim P, Marcos H, Ho VB, Mullick R, Summers RM.
Hepatic MR angiography: a multiobserver comparison of visualization methods.
AJR Am J Roentgenol. 176: 465-70, 2001.
323)  Foo TK, Ho VB, Hood MN, Marcos HB, Hess SL, Choyke PL.
High-spatial-resolution multistation MR imaging of lower-extremity peripheral vasculature with segmented volume acquisition: feasibility study.
Radiology. 219: 835-41, 2001.
324)  Choyke PL, Pavlovich CP, Daryanani KD, Hewitt SM, Linehan WM, Walther MM.
Intraoperative ultrasound during renal parenchymal sparing surgery for hereditary renal cancers: a 10-year experience.
J. Urol. 165: 397-400, 2001.
325)  Choyke PL, Daryanani K.
Intraoperative ultrasound of the kidney.
Ultrasound Q. 17: 245-53, 2001.
326)  Cebral JR, Löhner R, Choyke PL, Yim PJ.
Merging of intersecting triangulations for finite element modeling.
J Biomech. 34: 815-9, 2001.
327)  Summers RM, Choyke PL, Patronas NJ, Tucker E, Wise B, Busse MK, Brewer HB, Shamburek RD.
MR virtual angioscopy of thoracic aortic atherosclerosis in homozygous familial hypercholesterolemia.
J Comput Assist Tomogr. 25: 371-7, 2001.
328)  Chernoff A, Choyke PL, Linehan WM, Walther MM.
Parenchymal sparing surgery in a patient with multiple bilateral papillary renal cancer.
J. Urol. 165: 1623-4, 2001.
329)  Herring JC, Enquist EG, Chernoff A, Linehan WM, Choyke PL, Walther MM.
Parenchymal sparing surgery in patients with hereditary renal cell carcinoma: 10-year experience.
J. Urol. 165: 777-81, 2001.
330)  Foo TK, Ho VB, Hood MN, Hess SL, Choyke PL.
Preferential arterial imaging using gated thick-slice gadolinium-enhanced phase-contrast acquisition in peripheral MRA.
J Magn Reson Imaging. 13: 714-21, 2001.
331)  Thornbury JR, Ornstein DK, Choyke PL, Langlotz CP, Weinreb JC.
Prostate cancer: what is the future role for imaging?.
AJR Am J Roentgenol. 176: 17-22, 2001.
332)  Walther MM, Choyke PL.
Re: Pheochromocytoma coexisting with renal artery lesions.
J. Urol. 165: 2005-6, 2001.
333)  Pautler SE, Pavlovich CP, Mikityansky I, Drachenberg DE, Choyke PL, Linehan WM, Wood BJ, Walther MM.
Retroperitoneoscopic-guided radiofrequency ablation of renal tumors.
Can J Urol. 8: 1330-3, 2001.
334)  Yim PJ, Cebral JJ, Mullick R, Marcos HB, Choyke PL.
Vessel surface reconstruction with a tubular deformable model.
IEEE Trans Med Imaging. 20: 1411-21, 2001.
335)  Walther MC, Shawker TH, Libutti SK, Lubensky I, Choyke PL, Venzon D, Linehan WM.
A phase 2 study of radio frequency interstitial tissue ablation of localized renal tumors.
J. Urol. 163: 1424-7, 2000.
336)  Phillips JL, Walther MM, Pezzullo JC, Rayford W, Choyke PL, Berman AA, Linehan WM, Doppman JL, Gill Jr JR.
Predictive value of preoperative tests in discriminating bilateral adrenal hyperplasia from an aldosterone-producing adrenal adenoma.
J. Clin. Endocrinol. Metab. 85: 4526-33, 2000.
Click Here to View Collapsed Bibliography.

This page was last updated on 6/17/2014.